FDA Patent Rule Has Brands, Generics In War Of Words
Manufacturers of brand-name and generic drugs are pressuring the U.S. Food and Drug Administration on numerous proposals in a regulation with big implications for approval and exclusivity of copycat products, newly...To view the full article, register now.
Already a subscriber? Click here to view full article